Growth inflated by tariffs, margins miss guidance

27.9% YoY revenue growth; volume growth only 11% for basmati — tariff reduction (50%→10%) and commodity inflation drove 70%+ of gain

EBITDA likely ~₹363 Cr; OPM 11.2%, down from prior ~12.1%. Margin compression vs prior quarter despite revenue beat.

Revenue tracking well, but EBITDA margin target of 12% missed at 11.2–11.5%. Guidance contingent on tariff normalization and geopolitical stabilization.

Market share 23.1% (down from 23.7% in FY26 per analyst data). Household penetration up 20 lakh YoY — growth real, but share narrative softened by Nielsen reset claim.

Market dominance validated. Volume growth lower (27% normalized) than headline growth due to tariff and commodity mix — pricing, not volume, drove headline

Prior target 12% EBITDA recovery now at 11.2–11.5%. Organic restructuring cost and tariff benefit normalization imply margins stay under pressure through FY27.

Organic EBITDA margin 4% vs prior double-digit; now expect 1.5 years (by FY27-28) to return to double-digit, not this year.

RTH breakeven at ₹400 Cr revenue (2–3 years); new U.S. facility operationalizing Q1, expected to accelerate but path remains long.

Management stated eligible for U.S. duty refunds but 'have not booked any income yet, in talk with customers' — upside contingent, not assured.

10–12% long-term growth reiterated; normalized growth 19% this quarter (excl. tariff/inflation) suggests underlying 10–12% sustainable but near-term tailwinds temporary.

80–85% basmati is irrigated (canal/groundwater), 14–15% rain-dependent. Historical data shows limited red alert; by mid-August will have clarity. Confident on passing inflation to consumer historically.

Focus on market creation, shift loose to branded basmati. Gained share last quarter. Launched I'm Organic in Daawat e-comm. Charging premium vs competitors.

Sales recorded at net basis; promotions netted off per accounting. Golden Star consolidation this quarter drove normalization vs prior year.

Changed from wholesale to CPG, infrastructure set. Expect 1.5 years for gradual improvement. By FY27-end, EBITDA ₹70–80 Cr (currently 4%).

Breakeven at ₹400 Cr revenue, 2–3 years. New U.S. facility coming online. On track despite near-term margin pressure.

Core business, will remain. Play premium/mid-segment, not lower. Growth 15% range. Distributor and direct mix by country.

At optimum supplier funding level. 4–5 days legroom possible but not major further reduction.

Nielsen reset methodology 2–3 years ago; this quarter improved. Strong #1 position in core states (MH, Gujarat, MP). 40%+ e-commerce share, +20 lakh household penetration.

Eligible; partly received Q1. Not yet booked income; in talks with customers.

Inflation in commodity passed on + tariff (10% U.S. duty).

Both 5–10% growth range; Jasmine slightly faster. Jasmine 3x larger market. Basmati has higher EBITDA margin, Jasmine higher ROIC (120-day WC vs longer).

Normalized growth 19% this quarter suggests tariff/inflation boosted headline; underlying organic 10–12% realistic but cyclical

Current negative trajectory; requires successful CPG ramp in Europe, U.S. to accelerate from ₹254 Cr baseline

U.S. facility operationalization key; breakeven ₹400 Cr revenue in 2–3 years; currently ~₹50 Cr run-rate suggests 8x growth needed

Small base, freight volatility risk; premium/mid-segment focus limits upside

Stable at 13% this quarter despite tariff/freight headwinds; management confident on pricing power

Came in 11.2–11.5% this quarter, down from 12.1% prior. Organic 4% drag will persist 1–1.5 years

Currently 4%; path requires 3–4x improvement over 1.5 years; restructuring execution risk

Doubled RTH capacity, expanded European organic facilities. No explicit FY27 capex guide given this call; ROCE 21.1% suggests disciplined spend

Tariff benefit (50%→10% U.S.) and commodity inflation accounted for ~70% of Q1 growth; normalized underlying growth only 10–12%. Tariff normalization in H2/FY28 will reverse pricing gain; basmati volume (11% YoY) insufficient to offset.

Middle East freight ₹200→₹4,000/container; Europe/UK logistics 4.7% of revenue. Competitive intensity in ME prevents pass-through; margins turning negative in geography. Unresolved shipping disruptions.

Organic EBITDA margin collapsed to 4% from prior 35%+ due to CPG wholesale-to-direct shift and European capacity expansion. Guidance ₹70–80 Cr EBITDA by FY27-end (from ~₹10 Cr now) requires 7–8x improvement. 1.5-year recovery timeline extends into FY27-28.

RTH (ready-to-heat/cook) growing 13% YoY but EBITDA margin declining. Breakeven at ₹400 Cr revenue in 2–3 years; current run-rate ~₹50 Cr implies 8x growth needed. New U.S. facility operationalization key catalyst; delays would extend timeline and burn cash.

Market share 23.1% (down from 23.7% FY26 per analyst question). Management attributes to Nielsen methodology reset; claims market creation focus and share gain this quarter. But segment growth slowing as competitors ramp.